Ex-OpenAI CPO Kevin Weil launches Warp Sciences, an AI drug discovery startup, with $215M Series A
AnneliesGamble · x · 2026-10-22
Kevin Weil (former OpenAI CPO) has co-founded Warp Sciences, a new company applying frontier AI and robotics to drug discovery, aiming to move AI out of the browser and into the lab. The founding team includes DJ Patil, FAIR co-founder Manohar Paluri, and drug hunter Sol Reisberg.
The company raised a $215M Series A led by Lightspeed Venture Partners and plans to build scientific capacity in the US; early team members include researchers from the LLNL fusion ignition effort.
More from Venture
- Elice, EdTech-turned-AI-infra, completes year's largest tech IPO on KOSDAQ with wild 30% swings — ctjlewis · 2026-10-23
- Investor Matt Slotnick lays out three startup theses, led by an app server for agent apps — matt_slotnick · 2026-10-23
- Maxinsights Raises $30M Seed to Scale 2M Hours of Real-World Robot Training Data — CyberRobooo · 2026-10-23
- Sequoia's Doug Leone: Selling Google Early Cost Us Half a Trillion Dollars — davidsenra · 2026-10-23
- Sequoia's Stephanie Zhan launches early-stage AI fund with Sequoia, Jeff Dean as LPs — Azaliamirh · 2026-10-23
- Only 13% of companies see real returns from AI, Gartner survey of 2,002 CIOs finds — The Decoder · 2026-10-23